Literature DB >> 16487452

Binding kinetics of 123I[ADAM] in healthy controls: a selective SERT radioligand.

Julia Sacher1, Susanne Asenbaum, Nikolas Klein, Thomas Geiss-Granadia, Nilufar Mossaheb, Christian Poetzi, Trawat Attarbaschi, Rupert Lanzenberger, Christoph Spindelegger, Alexander Rabas, Georg Heinze, Robert Dudczak, Siegfried Kasper, Johannes Tauscher.   

Abstract

[123I]ADAM (2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine) is a promising radioligand for in-vivo quantification of serotonin transporters (SERT) using single photon emission computed tomography (SPECT) in man. We performed tracer kinetic analysis in various brain regions to determine the optimum equilibrium time for SERT quantification with [123I]ADAM and SPECT. Radiosyntheses of [123I]ADAM were performed at MAP Medical Technologies Oy, Tikkakoski, Finland. Thirty healthy male volunteers (21-41 yr) received between 104 and 163 MBq [123I]ADAM intravenously as a bolus. Consecutively, multiple SPECT scans were performed between 14 and 420 min post-injection (p.i.) using a Siemens Multispect 3 camera. Reconstruction was performed applying filtered back projection with a Butterworth filter (cut-off 0.7, order 7) in 128x128 matrices. Regions of interest (ROI) were drawn manually on the individual T1-weighted magnetic resonance image (MRI) comprising midbrain/hypothalamus for specific binding to SERT, and the cerebellum as reference region. After re-orientation to the MRI, the ROI template was applied to SPECT studies. We generated time-activity curves for the ROI and calculated the ratio countstarget/countscerebellum minus 1 (=V3'') as a measure for specific SERT binding. Counts were corrected for applied activity, acquisition time and body-weight. Peak uptakes were observed between 14 and 50 min after bolus injection. Counts per voxel were highest in the midbrain/hypothalamus, 798 (max. 872, min. 728), whereas 462 counts per voxel (max. 599, min. 412) were measured in the cerebellum at a mean time of 31 min p.i. Stable values for V3'' reached 205-320 min p.i. Mean peak V3'' value was 1.43 (95% CI 171-230) for the midbrain/hypothalamus at 205 min p.i. [123I]ADAM is a useful ligand for in-vivo quantification of human SERT by means of SPECT, with a comparatively better signal-to-noise ratio compared to beta-CIT. Our data suggest that the acquisition time for the SPECT scan is optimally, under pseudo-equilibrium conditions, between 205-320 min post-bolus injection of the tracer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16487452     DOI: 10.1017/S1461145706006511

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  2 in total

1.  5-Chloro-2-(2'-((dimethylamino)methyl)-4'-iodophenylthio)benzenamine: a new serotonin transporter ligand.

Authors:  Shunichi Oya; Seok-Rye Choi; Mei-Ping Kung; Hank F Kung
Journal:  Nucl Med Biol       Date:  2007-02       Impact factor: 2.408

2.  [I-123] ADAM and SPECT in patients with borderline personality disorder and healthy control subjects.

Authors:  Walter Koch; Nadine Schaaff; Gabriele Pöpperl; Christoph Mulert; Georg Juckel; Markus Reicherzer; Christoff Ehmer-von Geiso; Hans-Jürgen Möller; Ulrich Hegerl; Klaus Tatsch; Oliver Pogarell
Journal:  J Psychiatry Neurosci       Date:  2007-07       Impact factor: 6.186

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.